BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Filik M, Kir KM, Aksel B, Soyda Ç, Özkan E, Küçük ÖN, İbiş E, Akgül H. The Role of 18F-FDG PET/CT in the Primary Staging of Gastric Cancer. Mol Imaging Radionucl Ther 2015;24:15-20. [PMID: 25800593 DOI: 10.4274/mirt.26349] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Lee SY, Seo HJ, Kim S, Eo JS, Oh SC. Prognostic significance of interim 18 F-fluorodeoxyglucose positron emission tomography-computed tomography volumetric parameters in metastatic or recurrent gastric cancer. Asia Pac J Clin Oncol 2018;14:e302-9. [PMID: 29226597 DOI: 10.1111/ajco.12833] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
2 Kawanaka Y, Kitajima K, Fukushima K, Mouri M, Doi H, Oshima T, Niwa H, Kaibe N, Sasako M, Tomita T, Miwa H, Hirota S. Added value of pretreatment (18)F-FDG PET/CT for staging of advanced gastric cancer: Comparison with contrast-enhanced MDCT. Eur J Radiol 2016;85:989-95. [PMID: 27130061 DOI: 10.1016/j.ejrad.2016.03.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
3 Zhang Z, Zheng B, Chen W, Xiong H, Jiang C. Accuracy of 18F-FDG PET/CT and CECT for primary staging and diagnosis of recurrent gastric cancer: A meta-analysis. Exp Ther Med 2021;21:164. [PMID: 33456531 DOI: 10.3892/etm.2020.9595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jiang D, Chen X, You Z, Wang H, Zhang X, Li X, Ren S, Huang Q, Hua F, Guan Y, Zhao J, Xie F. Comparison of [68 Ga]Ga-FAPI-04 and [18F]-FDG for the detection of primary and metastatic lesions in patients with gastric cancer: a bicentric retrospective study. Eur J Nucl Med Mol Imaging 2021. [PMID: 34297193 DOI: 10.1007/s00259-021-05441-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Arslan E, Aksoy T, Gündoğan C, Şen Ç, Yılmaz Tatar S, Dursun N, Çermik TF. Metabolic Characteristics and Diagnostic Contribution of 18F-FDG PET/CT in Gastric Carcinomas. Mol Imaging Radionucl Ther 2020;29:25-32. [PMID: 32079385 DOI: 10.4274/mirt.galenos.2020.75537] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Machairas N, Charalampoudis P, Molmenti EP, Kykalos S, Tsaparas P, Stamopoulos P, Sotiropoulos GC. The value of staging laparoscopy in gastric cancer. Ann Gastroenterol 2017;30:287-94. [PMID: 28469358 DOI: 10.20524/aog.2017.0133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
7 Kobayashi S, Ogura M, Suzawa N, Horiki N, Katsurahara M, Ogura T, Sakuma H. 18F-FDG uptake in the stomach on screening PET/CT: value for predicting Helicobacter pylori infection and chronic atrophic gastritis. BMC Med Imaging. 2016;16:58. [PMID: 27756255 DOI: 10.1186/s12880-016-0161-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
8 Zheng D, Liu Y, Liu J, Li K, Lin M, Schmidt H, Xu B, Tian J. Improving MR sequence of 18F-FDG PET/MR for diagnosing and staging gastric Cancer: a comparison study to 18F-FDG PET/CT. Cancer Imaging 2020;20:39. [PMID: 32546207 DOI: 10.1186/s40644-020-00317-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Huntington CR, Walsh K, Han Y, Salo J, Hill J. National Trends in Utilization of Endoscopic Ultrasound for Gastric Cancer: a SEER-Medicare Study. J Gastrointest Surg. 2016;20:154-163; discussion 163-164. [PMID: 26553265 DOI: 10.1007/s11605-015-2988-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Luo M, Song H, Liu G, Lin Y, Luo L, Zhou X, Chen B. Comparison of DWI and 18F-FDG PET/CT for assessing preoperative N-staging in gastric cancer: evidence from a meta-analysis. Oncotarget 2017;8:84473-88. [PMID: 29137440 DOI: 10.18632/oncotarget.21055] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
11 Kwon HR, Pahk K, Park S, Kwon HW, Kim S. Prognostic Value of Metabolic Information in Advanced Gastric Cancer Using Preoperative 18F-FDG PET/CT. Nucl Med Mol Imaging 2019;53:386-95. [PMID: 31867074 DOI: 10.1007/s13139-019-00622-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
12 Sun G, Cheng C, Li X, Wang T, Yang J, Li D. Metabolic tumor burden on postsurgical PET/CT predicts survival of patients with gastric cancer. Cancer Imaging 2019;19:18. [PMID: 30902116 DOI: 10.1186/s40644-019-0205-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
13 Perlaza P, Ortín J, Pagès M, Buxó E, Fernández-Esparrach G, Colletti PM, Rubello D, Mayoral M, Sánchez N, Ruiz C, Ginés A, Fuster D. Should 18F-FDG PET/CT Be Routinely Performed in the Clinical Staging of Locally Advanced Gastric Adenocarcinoma? Clin Nucl Med 2018;43:402-10. [PMID: 29485442 DOI: 10.1097/RLU.0000000000002028] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
14 Marcus C, Subramaniam RM. PET/Computed Tomography and Precision Medicine: Gastric Cancer. PET Clin 2017;12:437-47. [PMID: 28867114 DOI: 10.1016/j.cpet.2017.05.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
15 Hess S, Bjerring OS, Pfeiffer P, Høilund-Carlsen PF. Personalized Clinical Decision Making in Gastrointestinal Malignancies: The Role of PET. PET Clin 2016;11:273-83. [PMID: 27321031 DOI: 10.1016/j.cpet.2016.02.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
16 Matsushita M, Fukata N, Omiya M, Nishio A, Okazaki K. Signet-ring cell carcinoma of the appendix: Primary or secondary tumor? Gastrointest Endosc 2018;88:197. [PMID: 29935612 DOI: 10.1016/j.gie.2018.01.005] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Nakajo M, Kajiya Y, Tani A, Jinguji M, Nakajo M, Yoshiura T. FLT-PET/CT diagnosis of primary and metastatic nodal lesions of gastric cancer: comparison with FDG-PET/CT. Abdom Radiol (NY) 2016;41:1891-8. [PMID: 27255652 DOI: 10.1007/s00261-016-0788-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]